BUDA

Buda Juice Inc. (BUDA) 10Y Growth Potential Analysis (2026)

Invetso Score: 5/10 — Balanced · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Revenue Growth Drivers

Score: 4.8 (Moderate)

Revenue growth evidence is limited by missing five-year CAGR data, so BUDA’s long-term compounding capacity cannot be validated against peers from disclosed metrics alone.

Low capex intensity at 4.7% of revenue suggests a relatively asset-light model, which can support incremental scaling better than more capital-heavy peers.

Negative net debt to EBITDA indicates excess balance-sheet capacity, which can fund expansion more flexibly than leveraged peers if growth opportunities emerge.

TTM ROIC of 9.4% shows only modest reinvestment efficiency, implying future revenue expansion may compound slower than higher-return peers with stronger capital productivity.

Market Tailwinds

Score:

No disclosed segment concentration or market-share data limits evidence of durable demand tailwinds, leaving BUDA less clearly advantaged than peers with visible category leadership.

The absence of reported R&D spending suggests limited proof of innovation-led demand creation, which weakens long-term expansion visibility versus peers investing heavily in product development.

A 23.5-day cash conversion cycle supports working-capital efficiency, but it reflects execution quality more than a structural market tailwind for multi-year revenue growth.

Without filing-based disclosure on addressable-market penetration, BUDA’s external growth runway remains harder to substantiate than peers with clearer geographic or product expansion channels.

Scalability Expansion

Score:

Low capex requirements improve scalability because incremental revenue can be added without proportionate asset buildout, a structural advantage versus capital-intensive peers.

Negative net debt provides reinvestment flexibility, allowing BUDA to fund expansion internally or through borrowing more easily than peers with constrained balance sheets.

ROIC near 9.4% indicates the business can reinvest profitably, but the return profile is not strong enough to signal top-tier compounding versus leading peers.

High valuation multiples imply the market already prices in growth, so future scaling must come from execution rather than multiple expansion, unlike cheaper peers.

Constraints Limitations

Score:

Missing historical growth, segment, and margin trend data creates a visibility constraint, making it difficult to confirm durable scaling versus peers with fuller disclosure.

ROIC below 10% suggests reinvested capital may generate only moderate incremental growth, capping long-term compounding relative to higher-return peers.

No evidence of R&D intensity or differentiated operating leverage limits proof that BUDA can accelerate revenue faster than similarly sized competitors.

Valuation at 5.9x sales and 27.9x EBITDA may constrain future upside if growth execution slows, because peers with lower entry multiples have more room to re-rate.

Overall Score

Score:

BUDA shows some structural support for growth through low capital intensity and balance-sheet flexibility, but limited disclosure and only moderate reinvestment returns keep long-term compounding below stronger peers.

Score Driver: Low Capital Intensity

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Buda Juice Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →